Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

4 Division of Endocrinology, Laboratory of Medicine, Departments of 1 Psychiatry, 2 Internal Medicine, and 3 Pathology, University of Cincinnati, Cincinnati, Ohio Submitted 1 April 2004 ; accepted in final form 20 September 2004 Bariatric surgeries, such as gastric bypass, result in dramatic and sustained weight loss that is usually attributed to a combination of gastric volume restriction and intestinal malabsorption. However, studies parceling out the contribution of enhanced intestinal stimulation in the absence of these two mechanisms have received little attention. Previous studies have demonstrated that patients who received intestinal bypass or Roux-en-Y surgery have increased release of gastrointestinal hormones. One possible mechanism for this increase is the rapid transit of nutrients into the intestine after eating. To determine whether there is increased secretion of anorectic peptides produced in the distal small intestine when this portion of the gut is given greater exposure to nutrients, we preformed ileal transpositions (IT) in rats. In this procedure, an isolated segment of ileum is transposed to the jejunum, resulting in an intestinal tract of normal length but an alteration in the normal distribution of endocrine cells along the gut. Rats with IT lost more weight ( P < 0.05) and consumed less food ( P < 0.05) than control rats with intestinal transections and reanastomosis without transposition. Weight loss in the IT rats was not due to malabsorption of nutrients. However, transposition of distal gut to a proximal location caused increased synthesis and release of the anorectic ileal hormones glucagon-like peptide-1 (GLP-1) and peptide YY (PYY; P < 0.01). The association of weight loss with increased release of GLP-1 and PYY suggests that procedures that promote gastrointestinal endocrine function can reduce energy intake. These findings support the importance of evaluating the contribution of gastrointestinal hormones to the weight loss seen with bariatric surgery. glucagon-like peptide-1; peptide YY; obesity surgery; ileum Address for reprint requests and other correspondence: A. D. Strader, Univ. of Cincinnati, Genome Research Institute, Dept. of Psychiatry, 2071 E. Galbraith Rd., Reading, OH 45237 (E-mail: april.strader{at}uc.edu )